FemTech Startups

Veera develops supplements and wellness products designed specifically for women's biology and hormones, with formulations tested on female physiology. The company focuses on evidence-backed, clean, plant-based products for the women's health market.

2 investors

VitruvianMD is building an AI-based fertility group that applies artificial intelligence to digitize the IVF process, targeting infertility treatment for clinics and couples. The company has deployed its technology for testing in more than 10 fertility clinics internationally, including in South Africa, Saudi Arabia, the UK, and Taiwan, and is pursuing CE Mark approval for Europe.

2 investors

Viv sells sustainable period care products, including a beginner-friendly menstrual disc, menstrual cup, organic cotton tampons, and bamboo pads and liners, along with a plant-based disc/cup wash. The products emphasize natural, toxin-free, and compostable materials for consumers seeking eco-friendly menstrual care.

2 investors

Watkins-Conti develops Yōni.Fit, a medical device for women's pelvic health that received FDA 510(k) clearance in August 2024 after a national clinical trial conducted by urogynecologists at Stanford, NYU, and Jefferson Health.

2 investors

Luna is a mobile app for teenage girls covering periods, puberty and growing up, offering period and mood tracking, medically verified anonymous Q&A, and educational articles, videos and quizzes. Its content is verified by medical experts and it serves teens and their parents across many countries.

2 investors

Wile makes plant-derived, naturopath-formulated supplements and rituals for women over 40 to manage perimenopause and menopause symptoms such as stress, mood, irritability, and burnout. The brand offers herbal formulas using adaptogens, phytoestrogens, and nervines.

2 investors

Women's Health is a media brand publishing articles, guides, podcasts, and video series on fitness, nutrition, beauty, and health topics aimed at women. It also offers subscription-based (WH+) workout and nutrition plans covering strength training, muscle building, and longevity.

2 investors

XbyX develops plant-based nutritional supplements with plant extracts and micronutrients aimed at supporting women's hormonal balance and energy from midlife through menopause and perimenopause. The direct-to-consumer brand targets women aged 40 and older in the German market.

2 investors

Xella is a women's precision health platform that combines multi-omic diagnostic testing with personalized clinical care, analyzing biological data to detect signs of 130+ conditions that often go undiagnosed in women. It offers a membership including physician-reviewed results, personalized care plans, and support across fertility, reproductive, hormonal, metabolic, and longevity health, aimed at women in the U.S.

2 investors

Your KAYA is a Polish direct-to-consumer brand selling body, face, and intimate care cosmetics along with shaving products, dietary supplements, and organic cotton period products. It offers dermocosmetics and personal care routines, including menstrual, shaving, and (peri)menopause care, available through one-time purchase or subscription.

2 investors

EXORPHIA develops extracellular vesicle (EV) technology for assisted reproductive medicine, focusing on cell-free IVF culture medium additives to improve embryo development and fertilization success rates. The company targets fertility clinics and academic institutions in reproductive medicine.

2 investors

Develops a PCR-based chromosome testing technology called SinChro™ that measures cellular aging to assess natural fertility potential. Offers a fertility testing service and is developing in-vitro diagnostics to detect chromosomal abnormalities in myelodysplastic syndrome.

1 investor

And Sisters offers period care products, including a menstrual cup (Mooncup) and other menstrual products made with science-backed ingredients. The brand sells its products online and in retail stores across the UK.

1 investor

Afynia develops diagnostic tools focused on women's health, with an emphasis on endometriosis detection through diagnostic biomarkers. The company operates a CLIA laboratory and works on molecular biology testing for reproductive health conditions.

1 investor

Ahma & Co operates postpartum retreats offering recovery support, newborn care, and education for new mothers and their partners during the first weeks after birth. Its first location opened in 2024 at a resort in Orange County, California, serving a small number of families at a time.

1 investor

OVY makes water-based suppositories for managing severe pelvic pain associated with conditions like endometriosis and uterine fibroids during menstruation. The product is designed for patients with pelvic floor muscle tension and aims to provide rapid pain relief without disrupting vaginal health.

1 investor

AIVF builds an AI-powered platform for IVF clinics that provides automated end-to-end embryo evaluation based on visual quality, morphokinetics, and ploidy probability, along with team communications and analytics tools. It serves IVF care teams including embryologists and andrologists in the fertility and reproductive health field.

1 investor

Almond provides obstetric and gynecologic care through both in-person clinics and telehealth, using back-office technology designed to optimize physician schedules and employing a broader team of care providers to reduce patient wait times.

1 investor

American-Sino (美华) operates private hospitals and clinics in Shanghai, including a women's and children's hospital, medical centers, pediatric and maternity care facilities. It provides medical services across departments such as obstetrics and gynecology, pediatrics, dermatology, dentistry, traditional Chinese medicine, and general practice.

1 investor

Ansella Therapeutics develops novel vaginal formulations for women's health conditions using biomimetic materials science and biomedical engineering, focused on treating menopause, vaginal dryness, dyspareunia, vaginal mucositis, endometriosis, uterine fibroids, and vaginal infections.

1 investor

1 investor

Apricotton is a teen bra brand based in Toronto that designs bras engineered to grow with adolescents through multiple stages of puberty, eliminating the need for frequent replacements as bodies develop. The company serves young girls navigating puberty by offering comfortable, inclusive intimate apparel designed with input from their target market.

1 investor

Apricotton designs adjustable bras for young girls and teens going through puberty, including the stretchy Cloud Bra with removable padding that grows with the wearer. The brand focuses on making first-time bra shopping easier and more comfortable for young women and their parents.

1 investor

Asieris (亚虹医药) is a pharmaceutical company developing diagnostic and therapeutic products focused on women's reproductive health and urologic cancers, including treatments for cervical precancerous lesions and bladder cancer. Its portfolio includes a non-invasive portable cervical photodynamic therapy product and a blue-light cystoscopy system for bladder cancer diagnosis, marketed in China.

1 investor